Margo Orlen

Also affiliated with University of Pennsylvania

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer”.

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Nature(2024)10.1038/s41586-024-07379-z

N/A

3.9DataRank · unranked

182 citations

Jingjing Jiang, Tanner C. Dalton, Álvaro Curiel‐García, A. Cole Edwards, Yingyun Wang +61 more

Translational regulation of TFH cell differentiation and autoimmune pathogenesis

Science Advances(2022)10.1126/sciadv.abo1782

N/A

0DataRank · unranked

8 citations

Sandra Pérez-Baos, Beth Walters, Margo Orlen, Angelina Volkova, Kelly V. Ruggles +3 more

Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.03.569791

N/A

0DataRank · unranked

11 citations

Jingjing Jiang, Alvaro Curiel-Garcia, Yingyun Wang, Bianca J. Lee, Margo Orlen +42 more

N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance

JCI Insight(2024)10.1172/jci.insight.178804

N/A

0DataRank · unranked

11 citations

Rosemary E. Flock, Jayne C. McDevitt, William P. Vostrejs, Sydney L. Campbell, Margo Orlen +6 more

Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-4049

N/A

0DataRank · unranked

6 citations

Hoon Choi, Samantha B. Kemp, Emma E. Furth, Stephen Pickup, Cynthia Clendenin +7 more